Zobrazeno 1 - 10
of 28 719
pro vyhledávání: '"A. A. Baranov"'
Autor:
N. S. Baranova, L. A. Ovsyannikova, Ya. S. Ostapenko, N. N. Spirin, A. A. Baranov, M. S. Gris, A. S. Artyukhov, Yu. V. Manyakina
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 57-64 (2024)
An imbalance in the production of proand anti-inflammatory cytokines plays an important role in the pathogenesis of multiple sclerosis (MS) and chronic neuroborreliosis (CNB).Objective: to perform a comparative analysis of cytokine production in pati
Externí odkaz:
https://doaj.org/article/3f151725433149fc967604ff11cf7b62
Autor:
A. A. Baranov, E. A. Aseeva, S. K. Soloviev, N. Yu. Nikishina, E. A. Malygina, T. O. Abissova, Z. Yu. Pimenova, T. M. Reshetnyak, S. A. Makarov, N. A. Lapkina, A. M. Lila
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 71-77 (2024)
This article describes the experience of using the type I interferon inhibitor anifrolumab (AFM) in a patient with a torpid course of systemic lupus erythematosus. The reason for prescribing AFM was the need for a quick achievement of low disease act
Externí odkaz:
https://doaj.org/article/d7939f7d364b40d28150d2b59f8fe2fb
Autor:
S. K. Solovyev, N. L. Kozlovskaya, E. A. Aseeva, A. A. Baranov, N. Yu. Nikishina, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 1, Pp 55-64 (2024)
Lupus nephritis (LN) is considered to be one of the most frequent severe manifestations of systemic lupus erythematosus (SLE), its various colonic manifestations occur in at least 50% of SLE patients, both at the onset and at various stages of the di
Externí odkaz:
https://doaj.org/article/5b556084d5904e0991461f15a29a84bd
Autor:
N. A. Lapkina, A. A. Baranov, N. E. Abaytova, E. A. Leontyeva, N. V. Yaltseva, A. S. Shutov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 5, Pp 554-561 (2023)
The aim of the study was to evaluate in real clinical practice the effectiveness of therapy with an interleukin-6 inhibitor (olokizumab) in patients with rheumatoid arthritis (RA) in terms of clinical and laboratory activity of the disease, as well a
Externí odkaz:
https://doaj.org/article/d170c004cde24ad8883b3c8ef65dc9ac
Publikováno v:
Современная ревматология, Vol 17, Iss 4, Pp 50-56 (2023)
The problem of clinical and immunological heterogeneity of systemic lupus erythematosus (SLE) is of great interest, especially the combination of SLE and Sjögren's syndrome (SjS) determines a more favorable prognosis and specifics of therapy.Objecti
Externí odkaz:
https://doaj.org/article/dabd19f4a7cb474eb9e9cf00a3756ba1
Autor:
E. L. Nasonov, V. N. Amirjanova, Y. A. Olyunin, Y. V. Muravyev, A. A. Baranov, E. V. Zonova, E. N. Otteva, A. I. Zagrebneva, D. I. Abdulganieva, P. I. Pchelnikova
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 4, Pp 435-449 (2023)
Rheumatoid arthritis (RA) is the most frequent immunoinflammatory (autoimmune) rheumatic disease characterized by chronic erosive arthritis and systemic damage to internal organs. The data obtained in the course of basic research on deciphering the m
Externí odkaz:
https://doaj.org/article/622d326a6fcc4ceba244273a93e899a0
Autor:
N. A. Lapkina, A. A. Baranov, N. Yu. Levshin, A. A. Kolinko, L. A. Mineeva, A. S. Artyuhov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 4, Pp 475-484 (2023)
The aim of the study was to investigate the dynamics of clinical and laboratory parameters of inflammatory disease activity and cytokines in patients with rheumatoid arthritis (RA) against the background of olokizumab (OKZ) treatment.Materials and me
Externí odkaz:
https://doaj.org/article/77fc72293f0940d180661a4655bd6594
Autor:
A. A. Baranov, I. B. Vinogradova, O. N. Anoshenkova, O. V. Antipova, E. A. Bogdanova, Y. Y. Grabovetskaya, E. P. Ilivanova, A. N. Kalyagin, I. N. Kushnir, N. A. Lapkina, M. V. Mokrousova, O. B. Nesmeyanova, N. M. Nikitina, P. A. Shesternya, N. V. Yudina, E. Feist, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 61, Iss 3, Pp 307-319 (2023)
Aim. Switching to another biologic with the same mode of action provides greater opportunity for long-term management of patients with rheumatoid arthritis (RA). In clinical practice, especially in the context of the COVID-19 pandemic, such switching
Externí odkaz:
https://doaj.org/article/cf4c379b9f39436f8f4c659e8754ef3b
Autor:
N. M. Bikbova, M. Kh. Mazanov, M. A. Sagirov, N. I. Kharitonova, A. A. Baranov, I. A. Argir, I. R. Mingalimova, S. Yu. Kambarov
Publikováno v:
Трансплантология (Москва), Vol 15, Iss 1, Pp 46-60 (2023)
Ischemic heart disease holds the leading position in the structure of cardiovascular diseases. Early reperfusion therapy for acute myocardial infarction led to a decrease in mortality and severe complications of coronary artery disease. Despite advan
Externí odkaz:
https://doaj.org/article/fb9b2e0a7a234344adc93c38ef79464f
Autor:
A. G. Badoyan, D. A. Khelimsky, A. A. Baranov, N. R. Obedinskaya, T. A. Bergen, V. Yu. Usov, S. N. Manukyan, O. V. Krestyaninov
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 9 (2023)
Aim. To obtain extended data on the impact of collateral circulation on the recovery of left ventricular (LV) function after recanalization of chronic coronary total occlusion (CTO), especially in patients with reduced left ventricle ejection fractio
Externí odkaz:
https://doaj.org/article/6e4967a1b2054da0b97f9e360b678164